ResearcherUniversity of MissouriActive in the last 2 years
Ming Jun Yang
Matched on ORCID iD 0000-0002-4895-5864; OpenAlex author ID A5031831796. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers
Papers 6
- Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers16081470↗
- Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy. Co-author DOI 10.3390/cancers16101808↗
- A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance. Co-author DOI 10.1016/j.canlet.2023.216457↗
- Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. Last author DOI 10.3748/wjg.v28.i48.6827↗
- Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. Last author DOI 10.4251/wjgo.v14.i8.1456↗
- Diagnostic biomarkers for pancreatic cancer: An update. Co-author DOI 10.3748/wjg.v27.i45.7862↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chunye Zhang · 3 shared papers, 2021–2022 · strength 0.80
- Paper Diagnostic biomarkers for pancreatic cancer: An update. DOI 10.3748/wjg.v27.i45.7862↗
- Paper Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. DOI 10.3748/wjg.v28.i48.6827↗
- Paper Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. DOI 10.4251/wjgo.v14.i8.1456↗
- Eric T. Kimchi · 3 shared papers, 2023–2024 · strength 0.66
- Paper Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers16081470↗
- Paper Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy. DOI 10.3390/cancers16101808↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457↗
- Guangfu Li · 3 shared papers, 2023–2024 · strength 0.66
- Paper Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers16081470↗
- Paper Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy. DOI 10.3390/cancers16101808↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457↗
- Shuai Liu · 2 shared papers, 2022 · strength 0.52
- Olamide Tosin Olaoba · 2 shared papers, 2024 · strength 0.48
- Nan Lyu · 1 shared paper, 2023 · strength 0.18
- Jing Zhou · 1 shared paper, 2023 · strength 0.18
- Kun Cheng · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.